Evidence map›Paper›PMID 33466884›Full record

ReviewDiagnostics (Basel, Switzerland)2021

SARS-CoV-2 in Mexico: Beyond Detection Methods, Scope and Limitations.

Cynthia Martinez-Liu, Natalia Martínez-Acuña, Daniel Arellanos-Soto, Kame Galan-Huerta, Sonia Lozano-Sepulveda, María Del Carmen Martínez-Guzmán, Ana Maria Rivas-Estilla

Open access · goldAbstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Cynthia Martinez-LiuDepartment of Biochemistry and Molecular Medicine and Hospital Universitario "Dr. Jose E. Gonzalez", Universidad Autonoma de Nuevo León, Monterrey 64460, Mexico.
Natalia Martínez-AcuñaDepartment of Biochemistry and Molecular Medicine and Hospital Universitario "Dr. Jose E. Gonzalez", Universidad Autonoma de Nuevo León, Monterrey 64460, Mexico.
Daniel Arellanos-SotoDepartment of Biochemistry and Molecular Medicine and Hospital Universitario "Dr. Jose E. Gonzalez", Universidad Autonoma de Nuevo León, Monterrey 64460, Mexico.
Kame Galan-HuertaDepartment of Biochemistry and Molecular Medicine and Hospital Universitario "Dr. Jose E. Gonzalez", Universidad Autonoma de Nuevo León, Monterrey 64460, Mexico.ORCID 0000-0002-3495-0528
Sonia Lozano-SepulvedaDepartment of Biochemistry and Molecular Medicine and Hospital Universitario "Dr. Jose E. Gonzalez", Universidad Autonoma de Nuevo León, Monterrey 64460, Mexico.
María Del Carmen Martínez-GuzmánInstituto Tecnologico de Tlahuac II, Tecnologico de Mexico, Mexico City 13550, Mexico.
Ana Maria Rivas-EstillaDepartment of Biochemistry and Molecular Medicine and Hospital Universitario "Dr. Jose E. Gonzalez", Universidad Autonoma de Nuevo León, Monterrey 64460, Mexico.ORCID 0000-0003-2311-2534
Universidad Autónoma de Nuevo León · MX

Funding

Consejo Nacional de Ciencia y Tecnología 312135
6 · The paper itself

Abstract

The new coronavirus that was first identified in December 2019 in Wuhan China, now called SARS-CoV-2, which causes the disease called COVID-19, has spread from China to the entire world in a few months. Due to its contagious potential (R0: 5.7) and because there is still no effective treatment to stop the infection, and a vaccine for prevention it is not yet available to the general population, COVID-19 is currently considered a global health problem. The need to implement sensitive methods for the identification of individuals with COVID-19 has led to the development of different molecular and immunological tests. The importance of a timely and accurate diagnosis is essential to determine the course of the pandemic. The interpretation of the results obtained by each test as well as the factors that affect these results have not been fully described. In this review, we describe and analyze the different SARS-CoV-2 detection methods that have been performed in Mexico and are available worldwide, outlining their strengths and weaknesses. Further, a broader perspective of the correct use and interpretation of the results obtained with these diagnostic tools is proposed to improve the containment strategy and identify the true impact of the pandemic.

Indexed as

antibodiesCLIACOVID-19diagnostic testELISAIgGIgMimmune host responseimmunoassaylateral flow assayrapid testSARS-CoV-2viral detection

Identifiers

PMID33466884
PMCPMC7830507
OpenAlexW3119754186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.